Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Reinforces the skin barrier and enhances elasticity with consistent use
8, S5S14
Goldberg DM, Spooner RJ
Johnson and Johnson retained the top position at $24.1 billion, while Novo Nordisk climbed from 9th in 2025 to 5th in Q1 2026 on the strength of its expanding GLP-1 portfolio
Most patients describe it as a quick pinch with minimal discomfort
Current pharmacologic therapy includes inhaled corticosteroids (ICS)/formoterol as required (PRN) or regular low dose ICS stepping up to combination inhaled steroids and long acting beta agonists (ICS/LABA) with additional therapies including leukotriene receptor antagonists (LTRA) or long acting anti-muscarinic agents (LAMA) to biologics, all on top of reliever therapies which can be a beta agonist or an ICS/Formoterol combination
US$ 22.90
US$ 20.54
US$ 23.55
US$ 22.37
US$ 27.67
